Winchester, MA, United States of America

J Keith Joung

This inventor holds 79 USPTO granted patents and 37 published patent applications, plus 6 CIPO patents and 17 EPO patents, primarily in Gene Editing Technologies (CPC class C12N). Top assignees: The General Hospital Corporation, Harvard College, Massachusetts Institute of Technology. Active years: 1999-2026.

USPTO Granted Patents = 79 (Patent Applications = 37)

% Patents Active = 98.7

CIPO Patents = 6 (Patent Applications = 21)

EPO Patents = 17 (Patent Applications = 47)

Average Co-Inventor Count = 2.5

ph-index = 18

Forward Citations = 1,361(Granted Patents)

Forward Citations (Not Self Cited) = 1,150(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2021)
Winchester, MA (US) (1999 - 2024)

Company Filing History:

74 out of 3,070

The General Hospital Corporation

Massachusetts Institute of Technology

patents

4. 1 out of 18

Beam Therapeutics Inc.

Fox Chase Cancer Center

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

CRISPR

Gene Regulation

Nuclease

Base Editing

Virus-Like Particles

Homology-Directed Repair

RNA-Guided

Precision Editing

Genome Editing

PAM Specificity

TAL Proteins

In Vitro Assays

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649913 - Variants of CRISPR from Prevotella and Francisella 1 (Cpf1) (2026-06-09),

2. 12630821 - Selective curbing of unwanted RNA editing (SECURE) DNA base editor variants (2026-05-19),

3. 12601009 - HIGHLY SENSITIVE IN VITRO ASSAYS TO DEFINE SUBSTRATE PREFERENCES AND SITES OF NUCLEIC-ACID BINDING, MODIFYING, AND CLEAVING AGENTS (2026-04-14),

4. 12590299 - Variants of CRISPR from Prevotella and Francisella 1 (Cpf1) (2026-03-31),

5. 12404525 - Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells (2025-09-02),

6. 12351815 - Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells (2025-07-08),

7. 12351814 - Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells (2025-07-08),

8. 12319938 - Enhanced virus-like particles and methods of use thereof for delivery to cells (2025-06-03),

9. 12286641 - Methods for increasing efficiency of nuclease-induced homology-directed repair (2025-04-29),

10. 12241096 - Engineered CRISPR-Cas9 nucleases with altered PAM specificity (2025-03-04),

11. 12202861 - Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1 (2025-01-21),

12. 12180520 - Engineered CRISPR-Cas9 nucleases with altered PAM specificity (2024-12-31),

13. 12173339 - Variants of Cpf1 (Cas12a) with altered PAM specificity (2024-12-24),

14. 12152254 - TAL-Tet1 fusion proteins and methods of use thereof (2024-11-26),

15. 12133884 - Methods of substituting pathogenic amino acids using programmable base editor systems (2024-11-05),

Title: The Innovative Journey of J Keith Joung

Introduction: J Keith Joung is a renowned inventor hailing from Winchester, MA (US). He has made significant contributions to the field of biotechnology and genetics through his groundbreaking inventions and patents.

Latest Patents: J Keith Joung holds several patents in the field of genome editing technologies, including CRISPR-based systems for precise gene editing and manipulation. His innovative work has revolutionized the way genetic research is conducted.

Career Highlights: With a background in molecular biology and biochemistry, J Keith Joung has established himself as a leading figure in the field of genome editing. He has published numerous research papers and has been recognized with prestigious awards for his contributions to science and technology.

Collaborations: Throughout his career, J Keith Joung has collaborated with top research institutions, universities, and biotechnology companies to further advance the field of genetic engineering. His collaborative efforts have led to the development of cutting-edge technologies with far-reaching implications.

Conclusion: J Keith Joung's passion for innovation and his relentless pursuit of scientific excellence have solidified his reputation as a trailblazer in the field of biotechnology. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of genetics.